Left ventricular dysfunction in an idiopathic pulmonary fibrosis patient on nintedanib

Nintedanib, a tyrosine kinase inhibitor, is approved for the treatment of idiopathic pulmonary fibrosis. We report a case of left ventricular dysfunction in a patient with idiopathic pulmonary fibrosis treated with nintedanib, which recovered after cessation of nintedanib. Nintedanib may induce left...

Descripción completa

Detalles Bibliográficos
Autores principales: Imai, Ryosuke, Tomishima, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017142/
https://www.ncbi.nlm.nih.gov/pubmed/32082576
http://dx.doi.org/10.1002/rcr2.533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017142/
https://www.ncbi.nlm.nih.gov/pubmed/32082576
http://dx.doi.org/10.1002/rcr2.533

Ejemplares similares